In fact, YAP activators ameliorated symptoms and disease phenotypes in different HD models86,87, and modulation of YAP activity rescued key HD-related neurodevelopmental phenotypes in neuruloids carrying mHTT88. This evidence concerns the gene YAP1 and Huntington disease.